Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Harvard Business School
AstraZeneca
McKinsey
Moodys

Last Updated: August 10, 2022

Details for Patent: 6,500,814


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 6,500,814
Title: Hormonal contraceptive
Abstract:The present invention relates to a hormonal contraceptive product having two hormonal components, an estrogen and a gestagen, and a process for the combined, continuous administration of the product of the invention.
Inventor(s): Hesch; Rolf-Dieter (Constance, DE)
Assignee: Wyeth Pharmaceuticals (St. Davids, PA)
Application Number:09/508,648
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,500,814
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 6,500,814

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,500,814

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 39 916Sep 11, 1997
PCT Information
PCT FiledSeptember 03, 1998PCT Application Number:PCT/DE98/02636
PCT Publication Date:March 18, 1999PCT Publication Number: WO99/12531

International Family Members for US Patent 6,500,814

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 241361 See Plans and Pricing
Australia 1140999 See Plans and Pricing
Germany 19739916 See Plans and Pricing
Germany 59808545 See Plans and Pricing
Denmark 1011682 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Colorcon
AstraZeneca
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.